Q3 2025 · 13F-HR
TPG GP A, LLCholdings as filed
Filed 2025-11-14 · accession 0001999371-25-017885
$1.84B
Reported value
9
Positions
2025-09-30
Period end
The Brief · TPG GP A, LLC · Q3 2025
AI · grounded in 13F
TPG GP A, LLC established a new position in LifeStance Health Group Inc LFST valued at $883.9M. The fund also initiated new stakes in Life Time Group Holdings Inc LTH for $492.1M and Sionna Therapeutics Inc SION for $198.4M. Other new additions include Amneal Pharmaceuticals Inc AMRX, Bicara Therapeutics Inc BCAX, and Ceribell Inc CBLL.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 53228F101 | LFST | LIFESTANCE HEALTH GROUP INC | $883.9M | 48.1% | 160,711,618 | Common | SOLE |
| 53190C102 | LTH | LIFE TIME GROUP HOLDINGS INC | $492.1M | 26.8% | 17,830,652 | Common | SOLE |
| 829401108 | SION | SIONNA THERAPEUTICS INC | $198.4M | 10.8% | 6,744,962 | Common | SOLE |
| 03168L105 | AMRX | AMNEAL PHARMACEUTICALS INC | $123.4M | 6.72% | 12,328,767 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $47.5M | 2.59% | 3,010,425 | Common | SOLE |
| 15678C102 | CBLL | CERIBELL INC | $45.6M | 2.48% | 3,967,422 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $23.2M | 1.26% | 18,716,306 | Common | SOLE |
| 87266M107 | TRTX | TPG RE FIN TR INC | $20.5M | 1.12% | 2,392,863 | Common | SOLE |
| 75120L100 | RLYB | RALLYBIO CORP | $1.5M | 0.08% | 3,028,414 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.